Application of high-throughput sequencing to circulating microRNAs reveals novel biomarkers for drug-induced liver injury.
about
Molecular regulation of miRNAs and potential biomarkers in the progression of hepatic steatosis to NASHTranslating extracellular microRNA into clinical biomarkers for drug-induced toxicity: from high-throughput profiling to validationmicroRNAs as pharmacogenomic biomarkers for drug efficacy and drug safety assessmentThe Identification of Circulating MiRNA in Bovine Serum and Their Potential as Novel Biomarkers of Early Mycobacterium avium subsp paratuberculosis Infection.MicroRNAs as Signaling Mediators and Biomarkers of Drug- and Chemical-Induced Liver Injury.Translational biomarkers of acetaminophen-induced acute liver injuryPotential of extracellular microRNAs as biomarkers of acetaminophen toxicity in children.Comprehensive microRNA profiling in acetaminophen toxicity identifies novel circulating biomarkers for human liver and kidney injury.Serum microRNA signatures as "liquid biopsies" for interrogating hepatotoxic mechanisms and liver pathogenesis in human.The plasma miR-125a, miR-361 and miR-133a are promising novel biomarkers for Late-Onset Hypogonadism.Beyond miR-122: Identification of MicroRNA Alterations in Blood During a Time Course of Hepatobiliary Injury and Biliary Hyperplasia in RatsIntegrated analysis of microRNA and mRNA expression profiles highlights the complex and dynamic behavior of toosendanin-induced liver injury in miceThe role for microRNAs in drug toxicity and in safety assessment.Development and regulatory application of microRNA biomarkers.A review of drug-induced liver injury databases.Epigenetics: new possibilities for drug discovery.Role of circulating microRNAs in liver diseasesUpregulation of microRNA-375 increases the cisplatin-sensitivity of human gastric cancer cells by regulating ERBB2.The transformation in biomarker detection and management of drug-induced liver injuryMicroRNA Biomarkers of Toxicity in Biological Matrices.The past and present of serum aminotransferases and the future of liver injury biomarkers.Role of miRNA and its potential as a novel diagnostic biomarker in drug-induced liver injury.MicroRNAs in injury and repair.Distribution of miRNA expression across human tissues.MicroRNA-122 can be measured in capillary blood which facilitates point-of-care testing for drug-induced liver injury.MagiCMicroRna: a web implementation of AgiMicroRna using shinyMicroRNA regulation of CYP 1A2, CYP3A4 and CYP2E1 expression in acetaminophen toxicitymiR-192-5p regulates lipid synthesis in non-alcoholic fatty liver disease through SCD-1.The Role of miRNAs in the Pathophysiology of Liver Diseases and Toxicity.Multiple microRNAs function as self-protective modules in acetaminophen-induced hepatotoxicity in humans.A longitudinal assessment of miR-122 and GLDH as biomarkers of drug-induced liver injury in the rat.Models of Drug Induced Liver Injury (DILI) - Current Issues and Future Perspectives
P2860
Q26778376-0402A0C9-D27B-4A38-A45E-DA2E2558FE81Q26778915-29C00F9D-CD54-4A6B-8589-A9FDFFAD2A2BQ26778918-C4B559A4-AC81-430F-8405-F1E792C8E3B5Q35720244-197F5E4F-657C-4520-A366-AE7FC5AEDC04Q35750622-04C146B5-F58C-4D28-B21F-AB1840F735A6Q36001451-77F9C668-ED7C-4E26-A96D-3D6D41C27B8BQ36022680-823BA94F-6995-44C4-BAAD-2D26267B98A9Q36187981-5C7F5728-4772-49B0-8D64-3034C070589BQ36381558-CEA7CB91-36CA-448C-BD0A-FCA605DBD532Q36713585-832567A2-FA39-42C8-810B-114E3283B942Q37228567-37AE6F37-D45E-4DF1-BE10-D09475CDCE01Q37310664-78E03BF9-D2A1-42FE-A307-1AD5373778D8Q38367620-C48A96FD-4A5D-4DBC-B6A6-419EA7F94C03Q38616581-C69C7BE1-042D-48B4-AA2F-4C95292AC74FQ38674530-E100A461-BC4B-42F8-9F25-5502A6EEE51BQ38737292-CF77D5C1-4A1D-4DFD-9022-F8FB4019320CQ38779843-BA2DC365-1571-43D8-B61E-B180E38052D0Q38792755-9272F46C-D936-4B28-A98B-CC3695583368Q38848580-5F83EF84-D16C-430C-BA93-20C884B4F851Q38909827-A01F0E72-B45B-4EDB-B8B7-62351EE1F538Q38926316-4917E73C-9DE9-44D4-95D5-5DF0BFED51EFQ39059921-DB10B93E-43AD-4109-821A-03DB3A3B6F87Q39304689-01928417-31D4-4C49-A261-123C8822B7B2Q39964196-43AD9599-8381-4E90-8B1A-BA4B2C2AF38EQ40309782-C051F21C-DA18-4ED0-B2A8-CA3C7E019D77Q41119161-F123C163-2D53-4FAF-BC7D-AD9D94399B46Q42364556-030B88F2-8424-4004-AC8B-7DE2ED4BD5F4Q47107195-46D4F333-8542-4894-85FF-30FEC441FFA0Q47553075-AB015A0D-D0C1-4150-9821-6516778891E1Q47631571-5C873721-6E85-4C38-99B0-19FD50383E5FQ53128125-3924429B-FF14-4DDA-A11D-414F396F8F8DQ58804131-5427C4A4-7B26-4E1E-BAF3-A3DB61136279
P2860
Application of high-throughput sequencing to circulating microRNAs reveals novel biomarkers for drug-induced liver injury.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Application of high-throughput ...... for drug-induced liver injury.
@ast
Application of high-throughput ...... for drug-induced liver injury.
@en
type
label
Application of high-throughput ...... for drug-induced liver injury.
@ast
Application of high-throughput ...... for drug-induced liver injury.
@en
prefLabel
Application of high-throughput ...... for drug-induced liver injury.
@ast
Application of high-throughput ...... for drug-induced liver injury.
@en
P2093
P2860
P356
P1476
Application of high-throughput ...... for drug-induced liver injury.
@en
P2093
Deborah A Burt
Jiri Aubrecht
Jos C Kleinjans
Julian Krauskopf
Kent J Johnson
Roscoe L Warner
Sandra M Claessen
Shelli J Schomaker
P2860
P304
P356
10.1093/TOXSCI/KFU232
P577
2014-10-29T00:00:00Z